Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ANTHEM, INC.

(ANTM)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Anthem : Stephens Adjusts Anthem's Price Target to $430 from $395, Keeps Overweight Rating

04/22/2021 | 10:45am EDT


ę MT Newswires 2021
All news about ANTHEM, INC.
06/10ANTHEMá : Downgraded by RBC to Sector Perform From Outperform, Price Target Kept..
MT
06/09ANTHEM, INC. : Ex-dividend day for
FA
06/07CORRECTION : Mizuho Securities Maintains Price Target for Anthem at $380, Reiter..
MT
06/07ANTHEMá : Mizuho Securities Adjusts Anthem PT to $320 From $380, Maintains Neutr..
MT
06/04ANTHEMá : Reaffirms Earnings Outlook for Full-year 2021
MT
06/04ANTHEM, INC.á : Regulation FD Disclosure (form 8-K)
AQ
05/27ANTHEM, INC.á : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
05/27ANTHEMá : Announces Appearance at Upcoming Conferences
BU
05/26INSIDER TRENDS : Anthem Insider Sale Scales Back 90-Days of Buys
MT
05/24INSIDER TRENDS : 90-Day Insider Buying Trend Eased Back with Sale of Anthem Shar..
MT
More news
Financials (USD)
Sales 2021 135 B - -
Net income 2021 5 950 M - -
Net Debt 2021 13 186 M - -
P/E ratio 2021 15,3x
Yield 2021 1,15%
Capitalization 92 160 M 92 160 M -
EV / Sales 2021 0,78x
EV / Sales 2022 0,71x
Nbr of Employees 83 400
Free-Float 99,3%
Chart ANTHEM, INC.
Duration : Period :
Anthem, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ANTHEM, INC.
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 23
Average target price 423,23 $
Last Close Price 369,21 $
Spread / Highest target 29,7%
Spread / Average Target 14,6%
Spread / Lowest Target -9,27%
EPS Revisions
Managers and Directors
NameTitle
Gail Koziara Boudreaux President, Chief Executive Officer & Director
John Edward Gallina Chief Financial Officer & Executive Vice President
Elizabeth E. Tallett Independent Chairman
Gloria M. McCarthy Chief Administrative Officer & Executive VP
Ramiro G. Peru Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
ANTHEM, INC.14.99%90 398
UNITEDHEALTH GROUP11.03%367 449
CIGNA CORPORATION11.43%79 599
HUMANA INC.3.22%54 638
CENTENE CORPORATION19.42%41 776
MOLINA HEALTHCARE, INC.12.63%13 989